Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence

In 2014, the Food and Drug Administration approved a new human papillomavirus 9-valent vaccine (9vHPV), targeting nine HPV types: HPV types 6, 11, 16, and 18, which are also targeted by the quadrivalent HPV vaccine (qHPV), plus five additional high cancer risk HPV types (HPV types 31, 33, 45, 52, an...

Descripción completa

Detalles Bibliográficos
Autores principales: SIGNORELLI, C., ODONE, A., CIORBA, V., CELLA, P., AUDISIO, R. A., LOMBARDI, A., MARIANI, L., MENNINI, F. S., PECORELLI, S., REZZA, G., ZUCCOTTI, G.V., PERACINO, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974698/
https://www.ncbi.nlm.nih.gov/pubmed/28446260
http://dx.doi.org/10.1017/S0950268817000747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974698/
https://www.ncbi.nlm.nih.gov/pubmed/28446260
http://dx.doi.org/10.1017/S0950268817000747

Ejemplares similares